Coopervision International Limited (cvil)
Clinical trials sponsored by Coopervision International Limited (cvil), explained in plain language.
Contact lens manufacturer, subsidiary of The Cooper Companies.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Can a new lens design improve overnight vision correction?
Disease control Not yet recruitingThis trial evaluates Paragon CRT contact lenses with a 5mm optic zone diameter, worn overnight to temporarily reshape the cornea and correct myopia and astigmatism. Participants aged 6 to 35 will wear the lenses daily for a short period, and their comfort and visual performance w…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New contact lens trial aims to simplify presbyopia prescriptions
Symptom relief Not yet recruitingThis study will test a new fitting experience for multifocal contact lenses in 25 people with presbyopia (age-related blurry near vision). Participants, who already wear certain contact lenses, will use an at-home trial kit with the new lens for 15 minutes daily. The goal is to s…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New study aims to sharpen contact lens prescriptions for astigmatism
Knowledge-focused Not yet recruitingThis study looks at whether a new, objective way to fit toric contact lenses (for astigmatism) gives the same results as the traditional subjective method. About 45 adults with astigmatism will have their lens prescription checked both ways. The goal is to see if the new method c…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC